The toxicokinetics of deltamethrin and its metabolite 4'-HO-deltamethr
in after single doses of 26 mg of deltamethrin/kg (oral) or 1.2 mg of
deltamethrin/kg (intravenous) were studied in male Wistar rats. Serial
blood samples were obtained after oral and intravenous administration
, Brain, vas deferens, and anococcygeus tissue samples were also obtai
ned after oral administration, Plasma, hypothalamus, cerebellum, front
al cortex, caudate putamen, hippocampus, medulla oblongata, vas defere
ns, and anococcygeus concentrations of deltamethrin and 4'-HO-deltamet
hrin were determined by a high-performance liquid chromatographic assa
y. The deltamethrin and 4'-HO-deltamethrin plasma profiles could be ad
equately described by a two-compartment open model. For deltamethrin a
nd 4'-HO-deltamethrin, the elimination half-lives (t 1/2(beta)) from p
lasma were 33.0 and 25.67 hr after iv and 38.50 and 30.13 hr after po
administration of deltamethrin parent compound. The apparent volume of
distribution [V-d(area)] and volume of distribution at steady state [
V-d(ss)] for deltamethrin were 5.33 and 2.04 liters, respectively, aft
er iv administration, suggesting a considerable diffusion of the pyret
hroid into tissue. The total plasma clearance of deltamethrin was the
same for both the oral and the iv routes-0.11 liter/hr. After the sing
le oral dose, deltamethrin was rapidly absorbed with a T-max of 1.83 h
r. The maximum plasma concentrations of deltamethrin and 4'-HO-deltame
thrin were 0.46 and 0.26 mu g/ml. The maximum plasma concentration of
4'-HO-deltamethrin was achieved at 3.29 hr. The oral bioavailability o
f deltamethrin was found to be 14.43 %. The tissue concentration time
data for deltamethrin and its metabolite 4'-HO-deltamethrin were found
to fit a one-compartment open model. Considerable concentrations of d
eltamethrin and 4'-HO-deltamethrin were found in the hypothalamus, cer
ebellum, frontal cortex, caudate putamen, hippocampus, medulla oblonga
ta, vas deferens, and anococcygeus tissues. The elimination half-lives
(t 1/2(el)) for both deltamethrin and 4'-HO-deltamethrin were somewha
t smaller for the cerebellum, frontal cortex, caudate putamen, medulla
oblongata, vas deferens, and anococcygeus tissues (range, 18-33 hr fo
r deltamethrin and 15-28 hr for 4'-HO-deltamethrin) than for plasma (t
1/2(el), 38.50 and 30.13 hr, respectively). Exceptions were seen for
the hypothalamus and hippocampus in which the t 1/2(el)'s for deltamet
hrin were 40.76 and 38.50 hr, respectively. Nervous tissue accumulatio
n of deltamethrin and its metabolite 4'-HO-deltamethrin was evidenced
by the tissue/plasma area under the concentration (AUG) versus time cu
rve ratios. The ratios of AUC(tissue)/AUC(plasma) for deltamethrin wer
e 2.32 in medulla oblongata, 295.30 in hypothalamus, and intermediate
in other tissues. (C) 1996 Academic Press, Inc.